Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Study of KHK7580 (Evocalcet) in Healthy Chinese Adults
NCT04206657Phase 1Completed
- Sponsor
- Kyowa Kirin
- Start
- Dec 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of ASP7991 in secondary hyperparathyroidism (SHPT) (5 arms), sponsored by Kyowa Kirin. Primary endpoints: Plasma KHK7580 concentration at each time point at Day 8, Time to Reach Maximum Observed Plasma Concentration at Day 8 and 5 more. Started Dec 2019; status: completed.
02
Drugs
ASP7991
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT04206657.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04206657.